CancerFree Biotech

Ex Vivo Avatar (EVA) is a patient-derived tumor organoid platform that uses 20 mL
of blood to generate 3D heterogeneous organoids reflecting each patient’s unique tumor biology. EVA supports precision treatment selection for patient care and accelerates drug development by
evaluating therapeutic efficacy in
patient-specific tumor models.

• Clinical Trial Collaboration
• Co-Development
• Collaborative R&D
• Strategic Alliance
• CRO